Department of Medicine

October 17, 2017

Researchers find novel mechanism of resistance to anti-cancer drugs

Vanderbilt investigators have discovered a novel non-genetic cause of resistance to the targeted anti-cancer therapy cetuximab. Their findings, reported this week in Nature Medicine, suggest a strategy for overcoming this resistance.

By Leigh MacMillan
October 13, 2017

New tools to combat kidney fibrosis

Vanderbilt investigators have developed a new mouse model of kidney fibrosis, which provides a platform for identifying new targets and treatment strategies.

By Leigh MacMillan
October 12, 2017

Researcher targets peanut allergies with Cohen Fund support

Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith’s research could fundamentally change allergy treatment.

By Leigh MacMillan
October 12, 2017

VIGH receives federal grants to fight kidney disease

Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria.

By Bill Snyder
October 5, 2017

Major international study testing therapy to prevent spread of HIV

Nine more volunteers are needed to complete a study at Vanderbilt University Medical Center (VUMC) that could lead to a way to prevent the spread of HIV (human immunodeficiency virus).

By Bill Snyder
September 28, 2017

Major grant to enhance kidney disease research

Vanderbilt’s Division of Nephrology and Hypertension has received a five-year, $5 million federal grant to provide core research services in the fight against kidney disease.

By Doug Campbell
September 28, 2017

VICC investigators land support from Komen Foundation

Three breast cancer investigators from Vanderbilt-Ingram Cancer Center (VICC) have been awarded research grants from Susan G. Komen, a nonprofit foundation devoted to supporting cancer research, community health outreach, advocacy and public policy initiatives.
By VUMC News and Communications
September 21, 2017

Grant supports Oates’ research on acetaminophen and stroke

John Oates, M.D., a pioneering clinical pharmacologist at Vanderbilt University Medical Center (VUMC), has been awarded a one-year, $20,000 grant from the Brain Aneurysm Foundation to support studies of the stroke-reducing potential of acetaminophen.
By Bill Snyder
September 14, 2017

Film documents photographer’s journey to regain quality of life

Nashville photographer Fred Dusel took a long draw on his ever-present trademark cigar as he studied a richly detailed carbon transfer print of wind-twisted driftwood on a barrier island beach in Georgia.
By Jill Clendening
September 11, 2017

Vanderbilt, Bayer collaborate to develop new therapies against kidney diseases

Vanderbilt University Medical Center (VUMC) and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.
By VUMC News and Communications
September 7, 2017

Community key to gender identity research effort

One of the key elements of the Vanderbilt Program for LGBTI Health, an innovative effort to improve health care for lesbian, gay, bisexual, transgender and intersex patients, is community engagement.
By Kathy Whitney
September 7, 2017

Combination therapy PrEP offers effective way to prevent HIV infection

Rates of new HIV infections in the United States are declining — except among men who have sex with men. Rates are particularly high among African-American and Hispanic men and especially in the South.
By Bill Snyder
August 31, 2017

Program for scientists to move discoveries into clinical practice

Vanderbilt University Medical Center (VUMC) has established a new career development program for scientists in implementation research. The goal is to speed the uptake and translation of scientific discoveries into routine clinical practice.
By Bill Snyder
1 … 86 87 88 89 90 … 124